MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

MetLife Earnings Call Signals Broad Growth and Strong Returns

Company update Earnings report AI-generated analysis

📈 MetLife delivered record quarterly adjusted earnings of $1.8 billion or $2.78 per share, with adjusted EPS rising 22% year over year to $2.85.

📊 Adjusted return on equity reached 19.6%, significantly above the company's 15% to 17% annual target range.

💰 The company deployed $3.8 billion of capital in 2025 and generated $2.8 billion of value of new business with a 19% internal rate of return.

📉 Direct expense ratio was 11.9% for the quarter, beating the 12.1% target thanks to technology and AI productivity gains.

🔄 MetLife repurchased $650 million of shares in Q3 and an additional $265 million in October, totaling about $3.5 billion returned year-to-date.

🌍 Group Benefits adjusted earnings rose 14% driven by favorable underwriting and improving working-age mortality ratios.

📈 EMEA adjusted earnings climbed 30% to $114 million while Latin America PFOs increased 22% led by Mexico and Chile.

💼 MetLife Investment Management assets under management reached $723 billion with adjusted earnings increasing 9% in the quarter.

🔮 Management expects full-year direct expense ratio to beat 11.1% and adjusted ROE to exceed the 15% to 17% target range.

⚠️ Asia quarterly sales fell 6% in constant currency, though less favorable underwriting partly offset investment gains.

🌎 Latin America earnings faced a $30 million headwind from negative encaje returns, creating an estimated year-over-year impact.

🤝 MetLife launched a multi-market embedded-insurance partnership with Revolut and plans to apply digital capabilities to Asia.

🏦 Japan's economic solvency ratio was 192%, reinforcing management's view of substantial financial flexibility across major markets.

🛡️ The company reported $4.1 billion in hyperscaler and data-center exposure, representing less than 1% of the general account with no delinquencies.

📉 Disability segment experienced slight increases in claim severity and submissions, requiring monitoring of macroeconomic trends.

Bullish Signals
  • MetLife reported record quarterly adjusted earnings of $1.8 billion or $2.78 per share, with adjusted EPS rising 22% year over year to $2.85.
  • Adjusted return on equity reached 19.6%, comfortably exceeding the company's 15% to 17% annual target range and positioning it to exceed full-year goals.
  • Top-line growth was reported across every operating segment, reducing reliance on any single business line while Group Benefits led underwriting performance.
  • The direct expense ratio was 11.9% for the quarter, below the 12.1% target, with technology and AI productivity gains offsetting integration costs.
  • MetLife repurchased $650 million of shares in Q3 and another $265 million in October, bringing year-to-date capital returned to about $3.5 billion.
  • Group Benefits adjusted earnings rose 14% driven by favorable underwriting and improving working-age mortality ratios, with the mortality ratio improving to 79.5%.
  • EMEA adjusted earnings climbed 30% to $114 million while Latin America PFOs increased 22%, demonstrating broad-based international growth.
  • MetLife Investment Management assets under management reached $723 billion with adjusted earnings increasing 9% in the quarter and margins expanding sequentially.
  • The company generated $2.8 billion of value of new business producing a 19% internal rate of return for the third consecutive year.
  • Japan's economic solvency ratio was 192%, well above the 170% to 190% range, reinforcing management's view of substantial financial flexibility.
Risk Factors
  • Asia quarterly sales fell 6% in constant currency against a strong comparison, with less favorable underwriting partly offsetting investment gains.
  • Latin America earnings increased only 3% in reported terms but fell 5% in constant currency due to a negative 3% encaje return creating a $30 million headwind.
  • Disability segment experienced slight increases in claim severity, higher submissions, and more mental and nervous claims requiring monitoring of macroeconomic trends.
  • MIM assets under management fell $25 billion sequentially primarily because higher rates reduced the value of public fixed-income holdings.
  • U.S. pension risk transfer activity was lighter year to date, though management characterized the slowdown as timing-related rather than structural.
Full Analysis
MetLife reported a strongly positive third-quarter earnings call, delivering record adjusted earnings of $1.8 billion or $2.78 per share. Excluding notable items, adjusted EPS rose 22% year over year to $2.85, while year-to-date growth also reached 22%. The company achieved an adjusted return on equity of 19.6%, comfortably exceeding its annual target range of 15% to 17%, and management indicated the business is well-positioned to exceed its full-year ROE goal. Top-line growth was reported across every operating segment, reducing reliance on any single business line. Group Benefits led underwriting performance with adjusted earnings rising 14% driven by favorable mortality trends, while RIS and Asia benefited from investments. Latin America and EMEA led revenue growth, with EMEA earnings climbing 30% and Latin America PFOs increasing 22%. The company also reported strong capital generation, deploying $3.8 billion in 2025 and generating $2.8 billion of value of new business. MetLife demonstrated disciplined expense management with a direct expense ratio of 11.9% for the quarter, below its 12.1% target, aided by technology and artificial intelligence productivity gains. The company repurchased $650 million of shares in the third quarter and another $265 million in October, bringing year-to-date capital returned to about $3.5 billion. Management highlighted substantial financial flexibility with a Japan solvency ratio of 192% and maintained key targets for full-year performance despite manageable headwinds in specific regions. Looking ahead, MetLife expects the full-year direct expense ratio to beat 11.1% and adjusted ROE to exceed its target range. The company guided fourth-quarter variable investment income between $400 million company-wide and $100 million to $120 million for Retirement and Income Solutions. While management noted watch points such as Asia sales declines and Latin American encaje pressure, the overall message was confident with a focus on organic growth and strict financial standards for any potential acquisitions.